Ajanta Pharma: Promoter creates pledge on 10.06 lakh shares for new loan

Ownership Changes View source PDF Explain this filing

AJANTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.0%Reaction day

₹3340.00

prior close

₹3357.90

announcement price

In-mkt

timing

Nifty Midcap 150market-0.2%+0.2% vs market

Pharmaceuticals peers, median of 165sector+0.2%-0.2% vs sector

On the reaction day the stock moved 0.2 pts more than Nifty Midcap 150 and 0.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.0

10m

+0.3

15m

+0.5

30m

+0.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.0-0.2+0.2+0.2-0.2

Next day

+1.0+0.2+0.9-0.3+1.4

-0.7-0.1-0.7-0.5-0.3

-1.7-1.7+0.1-1.2-0.4

-1.0-0.3-0.7-0.6-0.4

+0.8+1.0-0.2-0.1+0.8

+2.3+0.5+1.8+0.6+1.8

15d

+0.9-1.1+2.0-1.9+2.9

+5.1+2.1+3.0-0.8+5.9

+5.5+1.2+4.3+0.8+4.8

+4.8-5.1+9.9+0.3+4.4

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Aayush Agrawal Trust and Mr. Aayush Agrawal, promoters of Ajanta Pharma, have created a pledge on 10,06,726 equity shares (about 0.80 percent of total share capital) on 30 June 2026. The reason given is a new loan, with CTL Trusteeship Limited as the pledgee. After this event, the trust's encumbered holding rises to 10.83 percent of total share capital from 10.05 percent earlier.

Likely market impact

Routine promoter borrowing move but marginally raises encumbered stake. Watch for further pledges or any margin call triggers.